Ghost Tree Capital, LLC Biogen Inc. Transaction History

Ghost Tree Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $730,087 - $1.01 Million	3,750 New	3,750 $1 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $9.2 Million - $12 Million	-32,500 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$259.0 - $414.71 $3.24 Million - $5.18 Million	12,500 Added 62.5%	32,500 $11.3 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $4.32 Million - $5.07 Million	17,800 Added 809.09%	20,000 $5.6 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $472,520 - $711,260	-2,000 Reduced 47.62%	2,200 $539,000
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $1.11 Million - $1.28 Million	4,200 New	4,200 $1.19 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $840,645 - $1.11 Million	-3,250 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $873,762 - $1.11 Million	3,250 New	3,250 $1.03 Million

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.